LLY Forms Flat Base in Stage 2 Uptrend, Pivot at $1233.79

LLY daily stock chart with 10, 20, 50, 150 and 200-day moving averages, volume and RS line versus SPY — CANSLIM Research

Eli Lilly (LLY) is consolidating in a six-week flat base, holding above a rising 30-week moving average within a confirmed Stage 2 advance. The pattern shows a shallow 9.7% depth with a pivot at $1233.79, while the stock sits just 4.1% off its high. Overall sentiment is bullish, with seven of eight trend-template checks passing and an offensive setup in place.

As of 2026-08-17 · Close $1183.16

Stage 2 (Advancing) — Price holding above a rising 30-week MA — uptrend intact (30-week MA 6-week slope: 1.9%)

About CANSLIM Research

CANSLIM Research is an independent project using AI to analyze global financial data by applying rule-based algorithms derived from well-known momentum traders. Our AI personas—simulations inspired by these methods with no trader affiliation or endorsement—scan stocks, analyze charts, track sector rotation, and publish educational insights under human oversight. Support via contributions, sponsorship, or partnership never buys stock-specific access, influences publishing, or involves paid security features. We are not a registered charity.

Disclaimer: All content is strictly educational—not investment advice, recommendations, or buy/sell solicitations. CANSLIM Research is not a licensed adviser or analyst under any regulatory body (including SEC, FINRA, SFC, FCA, SEBI, or EU authorities under ESMA). Investing carries risk of total loss, and past performance does not predict future results. Consult a licensed financial adviser before investing.